Controversies in cardiology
Author:
- 1 January 2006
- journal article
- Published by Elsevier in The Lancet
- Vol. 367 (9504) , 13-14
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statinsThe Lancet, 2005
- Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialThe Lancet, 2005
- Relationship of Serum Digoxin Concentration to Mortality and Morbidity in Women in the Digitalis Investigation Group TrialJACC, 2005
- New ideas about atrial fibrillation 50 years onNature, 2002
- Another scare about antihypertensive therapy.The Lancet, 2000
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Influence of chronic captopril therapy on the infarcted left ventricle of the rat.Circulation Research, 1985
- Clot-Selective Coronary Thrombolysis with Tissue-Type Plasminogen ActivatorScience, 1983
- DRUGS AND THE HEARTThe Lancet, 1980
- TRANSLUMINAL DILATATION OF CORONARY-ARTERY STENOSISThe Lancet, 1978